These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 9359658)
1. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients. Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658 [TBL] [Abstract][Full Text] [Related]
2. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants. Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426 [TBL] [Abstract][Full Text] [Related]
3. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques. Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322 [TBL] [Abstract][Full Text] [Related]
5. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. Carmichael A; Jin X; Sissons P; Borysiewicz L J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890 [TBL] [Abstract][Full Text] [Related]
7. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560 [TBL] [Abstract][Full Text] [Related]
8. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634 [TBL] [Abstract][Full Text] [Related]
9. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417 [TBL] [Abstract][Full Text] [Related]
10. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197 [TBL] [Abstract][Full Text] [Related]
11. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. Dalod M; Dupuis M; Deschemin JC; Goujard C; Deveau C; Meyer L; Ngo N; Rouzioux C; Guillet JG; Delfraissy JF; Sinet M; Venet A J Clin Invest; 1999 Nov; 104(10):1431-9. PubMed ID: 10562305 [TBL] [Abstract][Full Text] [Related]
12. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791 [TBL] [Abstract][Full Text] [Related]
13. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. Hay CM; Ruhl DJ; Basgoz NO; Wilson CC; Billingsley JM; DePasquale MP; D'Aquila RT; Wolinsky SM; Crawford JM; Montefiori DC; Walker BD J Virol; 1999 Jul; 73(7):5509-19. PubMed ID: 10364299 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina. Kent SJ; Corey L; Agy MB; Morton WR; McElrath MJ; Greenberg PD J Clin Invest; 1995 Jan; 95(1):248-56. PubMed ID: 7814622 [TBL] [Abstract][Full Text] [Related]
15. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. Luzuriaga K; Holmes D; Hereema A; Wong J; Panicali DL; Sullivan JL J Immunol; 1995 Jan; 154(1):433-43. PubMed ID: 7995957 [TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302 [TBL] [Abstract][Full Text] [Related]
17. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338 [TBL] [Abstract][Full Text] [Related]
18. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075 [TBL] [Abstract][Full Text] [Related]
20. Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2. Abimiku AG; Franchini G; Aldrich K; Myagkikh M; Markham P; Gard E; Gallo RC; Robert-Guroff M AIDS Res Hum Retroviruses; 1995 Mar; 11(3):383-93. PubMed ID: 7786583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]